[Defibrinating treatment in children with severe nephrotic syndrome].
D012103:Batroxobin / Q000494:pharmacology / Q000627:therapeutic use*; D001809:Blood Viscosity / Q000187:drug effects; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000097:blood* / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000627:therapeutic use*
D010447:Peptide Hydrolases; D012103:Batroxobin
Próba leczenia defibrynujacego u dzieci z ciezkim zespołem nerczycowym.